SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-043096
Filing Date
2021-12-27
Accepted
2021-12-27 16:15:17
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10032244_defa14a.htm DEFA14A 24842
2 brhc10032244_defa14aslide1.jpg GRAPHIC 76094
3 brhc10032244_defa14aslide2.jpg GRAPHIC 80378
4 image001.jpg GRAPHIC 7079
  Complete submission text file 0001140361-21-043096.txt   251538
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37568 | Film No.: 211520755
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences